Tylenol MDL Highlights Expert Admissibility Headaches

By Rand Brothers and Courtney Block (May 2, 2024, 6:00 PM EDT) -- The In re: Acetaminophen — ASD-ADHD Products Liability Litigation[1] in the U.S. District Court for the Southern District of New York was brought by more than 600 plaintiffs who alleged that the labeling practices of the defendant manufacturers and retailers of acetaminophen products were deficient because they failed to warn that children may develop autism spectrum disorder or attention-deficit hyperactivity disorder from in utero exposure to the drug.[2]...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as